255 related articles for article (PubMed ID: 28498934)
1. Leveraging Genomic Data in Smoking Cessation Trials in the Era of Precision Medicine: Why and How.
Chen LS; Zawertailo L; Piasecki TM; Kaprio J; Foreman M; Elliott HR; David SP; Bergen AW; Baurley JW; Tyndale RF; Baker TB; Bierut LJ; Saccone NL;
Nicotine Tob Res; 2018 Mar; 20(4):414-424. PubMed ID: 28498934
[TBL] [Abstract][Full Text] [Related]
2. Pathways to precision medicine in smoking cessation treatments.
Chen LS; Horton A; Bierut L
Neurosci Lett; 2018 Mar; 669():83-92. PubMed ID: 27208830
[TBL] [Abstract][Full Text] [Related]
3. 2018 Langley Award for Basic Research on Nicotine and Tobacco: Bringing Precision Medicine to Smoking Cessation.
Bierut LJ
Nicotine Tob Res; 2020 Feb; 22(2):147-151. PubMed ID: 30855677
[TBL] [Abstract][Full Text] [Related]
4. Individualized Treatment for Tobacco Dependence in Addictions Treatment Settings: The Role of Current Depressive Symptoms on Outcomes at 3 and 6 Months.
Zawertailo LA; Baliunas D; Ivanova A; Selby PL
Nicotine Tob Res; 2015 Aug; 17(8):937-45. PubMed ID: 26180218
[TBL] [Abstract][Full Text] [Related]
5. The Value of Biosamples in Smoking Cessation Trials: A Review of Genetic, Metabolomic, and Epigenetic Findings.
Saccone NL; Baurley JW; Bergen AW; David SP; Elliott HR; Foreman MG; Kaprio J; Piasecki TM; Relton CL; Zawertailo L; Bierut LJ; Tyndale RF; Chen LS;
Nicotine Tob Res; 2018 Mar; 20(4):403-413. PubMed ID: 28472521
[TBL] [Abstract][Full Text] [Related]
6. Factors influencing the impact of pharmacogenomic prescribing on adherence to nicotine replacement therapy: A qualitative study of participants from a randomized controlled trial.
Wright AJ; Sutton S; Armstrong D; Aveyard P; Kinmonth AL; Marteau TM
Transl Behav Med; 2018 Jan; 8(1):18-28. PubMed ID: 29385578
[TBL] [Abstract][Full Text] [Related]
7. Physician barriers to incorporating pharmacogenetic treatment strategies for nicotine dependence into clinical practice.
Schnoll RA; Shields AE
Clin Pharmacol Ther; 2011 Mar; 89(3):345-7. PubMed ID: 21326262
[TBL] [Abstract][Full Text] [Related]
8. Toward precision smoking cessation treatment II: Proximal effects of smoking cessation intervention components on putative mechanisms of action.
Piper ME; Cook JW; Schlam TR; Smith SS; Bolt DM; Collins LM; Mermelstein R; Fiore MC; Baker TB
Drug Alcohol Depend; 2017 Feb; 171():50-58. PubMed ID: 28013097
[TBL] [Abstract][Full Text] [Related]
9. Toward the implementation of genomic applications for smoking cessation and smoking-related diseases.
Ramsey AT; Chen LS; Hartz SM; Saccone NL; Fisher SL; Proctor EK; Bierut LJ
Transl Behav Med; 2018 Jan; 8(1):7-17. PubMed ID: 29385591
[TBL] [Abstract][Full Text] [Related]
10. Attitudes toward Precision Treatment of Smoking in the Southern Community Cohort Study.
Senft N; Sanderson M; Selove R; Blot WJ; King S; Gilliam K; Kundu S; Steinwandel M; Sternlieb SJ; Warren Andersen S; Friedman DL; Connors E; Fadden MK; Freiberg M; Wells QS; Canedo J; Tyndale RF; Young RP; Hopkins RJ; Tindle HA
Cancer Epidemiol Biomarkers Prev; 2019 Aug; 28(8):1345-1352. PubMed ID: 31160346
[TBL] [Abstract][Full Text] [Related]
11. Precision Medicine for Tobacco Dependence: Development and Validation of the Nicotine Metabolite Ratio.
Allenby CE; Boylan KA; Lerman C; Falcone M
J Neuroimmune Pharmacol; 2016 Sep; 11(3):471-83. PubMed ID: 26872457
[TBL] [Abstract][Full Text] [Related]
12. Clinical neglect of nicotine dependence.
Sellman D
Aust N Z J Psychiatry; 2005 Oct; 39(10):847-8. PubMed ID: 16168011
[No Abstract] [Full Text] [Related]
13. The Use of the Nicotine Metabolite Ratio as a Biomarker to Personalize Smoking Cessation Treatment: Current Evidence and Future Directions.
Siegel SD; Lerman C; Flitter A; Schnoll RA
Cancer Prev Res (Phila); 2020 Mar; 13(3):261-272. PubMed ID: 32132120
[TBL] [Abstract][Full Text] [Related]
14. The association of dopamine pathway gene score, nicotine dependence and smoking cessation in a rural male population of Shandong, China.
Li S; Wang Q; Pan L; Li H; Yang X; Jiang F; Zhang N; Han M; Jia C
Am J Addict; 2016 Sep; 25(6):493-8. PubMed ID: 27490263
[TBL] [Abstract][Full Text] [Related]
15. Preparing the Way: Exploiting Genomic Medicine to Stop Smoking.
Bierut LJ; Tyndale RF
Trends Mol Med; 2018 Feb; 24(2):187-196. PubMed ID: 29307500
[TBL] [Abstract][Full Text] [Related]
16. Nicotine Dependence: Future Opportunities and Emerging Clinical Challenges.
Leone FT; Baldassarri SR; Galiatsatos P; Schnoll R
Ann Am Thorac Soc; 2018 Oct; 15(10):1127-1130. PubMed ID: 30059632
[No Abstract] [Full Text] [Related]
17. [Nicotine dependence and smoking cessation].
Dănciulescu D
Pneumologia; 2002; 51(1):70-1. PubMed ID: 12043282
[No Abstract] [Full Text] [Related]
18. Waterpipe tobacco smoking: The critical need for cessation treatment.
Ward KD; Siddiqi K; Ahluwalia JS; Alexander AC; Asfar T
Drug Alcohol Depend; 2015 Aug; 153():14-21. PubMed ID: 26054945
[TBL] [Abstract][Full Text] [Related]
19. Repeated measures latent class analysis of daily smoking in three smoking cessation studies.
McCarthy DE; Ebssa L; Witkiewitz K; Shiffman S
Drug Alcohol Depend; 2016 Aug; 165():132-42. PubMed ID: 27317043
[TBL] [Abstract][Full Text] [Related]
20. Smoking cessation in severe mental illness: what works?
Banham L; Gilbody S
Addiction; 2010 Jul; 105(7):1176-89. PubMed ID: 20491721
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
